VERA•benzinga•
Guggenheim Maintains Buy on Vera Therapeutics, Raises Price Target to $61
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 27, 2025 by benzinga